亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

ARF-BP1 as mediator of p53 dependent and independent tumor suppression

技术优势
A novel target for cancer therapy ARF has tumor suppressor activity that is p53 independent Since ARF-BP1 interacts with ARF and p53 but not with Mdm2, it is a useful therapeutic target in tumors that lack Mdm2 activity
技术应用
Assay for compounds that inhibit ARF-BP1 binding to p53 Inhibitors of ARF-BP1 binding to p53 can be further developed into potential broad spectrum cancer drugs Determination of ARF-BP1 status of tumors may have prognostic value where the cellular level of ARF-BP1 may inversely correlate with good prognosis ARF-BP1 could be used as a biomarker for pre-malignant tumors or for tumor staging and grading
详细技术说明
The present invention identifies ARF-BP1, a novel ubiquitin ligase, as a critical mediator of p53- dependent and p53-independent tumor suppression functions of ARF. ARF-BP1 directly binds and ubiquitinates p53. Inactivation of ARF-BP1 stabilizes p53 ...
*Abstract
None
*Inquiry
Cynthia LangColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
*IR
1694
*Principal Investigation
*Publications
ARF-BP1/Mule Is a Critical Mediator of the ARF Tumor Suppressor. D. Chen et. al, Cell, (2005) Volume 121, Issue 7, Pages 1071-1083.
*Web Links
USPTO: US 7,358,335
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备